An analysis of the 2025 AHA/ACC hypertension guidelines found that under the new guidelines, about 11% of adults ages 65 to 79 with stage I hypertension would no longer qualify for blood pressure ...

Although Canada historically has been a leader in hypertension treatment and control, rates have declined in the past decade, particularly among women and vulnerable groups. With the aim of improving ...

As more adults develop hypertension at younger ages, with many never reaching recommended treatment goals, updated clinical recommendations are changing how clinicians diagnose, monitor, and manage ...

Preventing and managing high blood pressure with healthy lifestyle behaviors, such as following a heart-healthy diet including reducing salt intake, staying physically active, maintaining a healthy ...

We sought to assess the validity of risk stratification table of Japanese Society of Hypertension (JSH) 2025 guideline, based on Scheie hypertensive fundus changes. We analyzed the data of medical ...

11.4 percent of adults aged 65 to 79 years with stage 1 hypertension would not be eligible under 2025 criteria. (HealthDay News) — Using the 2025 risk-guided criteria, 11.4 percent of untreated older ...

Based on the final consensus statement issued by the Joint Committee on Renal Denervation (RDN), the Japanese Society of Hypertension (JSH), the Japanese Circulation Society (JCS) and the Japanese ...

New groundbreaking results from a clinical trial reinforce the critical importance of personalized medicine in hypertension care. Results from the AIM-HY INFORM trial, presented today at the ESC ...

Please provide your email address to receive an email when new articles are posted on . Lifetime risk for hypertension is up to 90% among U.S. adults. Updated guidelines and a pipeline of novel drugs ...